Irisin May Reduce Plaque and Tau Tangle in Alzheimer Disease Model
Study findings suggest a possible new target pathway for therapies to prevent and treat Alzheimer disease.
Diagnosis & Disease Information
Odor Sensitivity Deficits May Predict Cognitive Decline in APOE ε4 Carriers
Researchers sought to assess the relationship between olfactory genotyping and cognitive decline due to Alzheimer disease.
Depression Diagnosis Tied to Increased Dementia Risk
Researchers sought to examine associations of early-, middle-, and late-life depression with the risk of developing dementia.
Blood Tests for Detecting Alzheimer Disease Show Promise: Research From AAIC 2023
Blood tests for Alzheimer disease may improve diagnostic accuracy and treatment options.
Alzheimer Disease Prevalence Highest in East, Southeast US
Researchers sought to estimate the prevalence and number of adults living with Alzheimer disease across US states and counties.
Dementia Risk Assessment Models Have Limited Ability in Predicting Disease
In a prospective, population-based study, researchers investigated the clinical utility of multifactorial risk prediction models in estimating patients’ 10-year dementia risk.
Incident Myocardial Infarction Tied to Faster Cognitive Decline Over Time
In an observational cohort study, researchers assessed whether incident MI is associated with changes in cognitive function after adjusting for pre-MI cognitive trajectories.
Can Daily Internet Use Alleviate Dementia Risk in Older Adults?
Researchers sought to assess the long-term risk for dementia in older adults with regular internet usage and compare dementia risk in baseline internet usage to educational level, race/ethnicity, sex and generation, as well as the potential detrimental effects of excessive usage.
Older Patients Who Survive Breast Cancer at Higher Risk for Dementia
Researchers sought to assess the risk for dementia among patients who are 5-year breast cancer survivors.
Anti-Amyloid-Beta Vaccine Candidate Fast Tracked for Alzheimer Disease
The designation was supported by initial interim safety and immunogenicity data from the phase 1b/2 ABATE trial.
- Loading...
Loading...
Loading... 
Loading...